BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4916020)

  • 1. Estrogen treatment for cancer of the prostate. Early results with 3 doses of diethylstilbestrol and placebo.
    Bailar JC; Byar DP
    Cancer; 1970 Aug; 26(2):257-61. PubMed ID: 4916020
    [No Abstract]   [Full Text] [Related]  

  • 2. Estrogen and survival data in carcinoma of the prostate.
    Bennett AH; Dowd JB; Harrison JH
    Surg Gynecol Obstet; 1970 Mar; 130(3):505-8. PubMed ID: 4905115
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence of cardiovascular disease and death in patients receiving diethylstilbestrol for carcinoma of the prostate.
    Blackard CE; Doe RP; Mellinger GT; Byar DP
    Cancer; 1970 Aug; 26(2):249-56. PubMed ID: 4916019
    [No Abstract]   [Full Text] [Related]  

  • 4. Current status of estrogen therapy for prostatic carcinoma.
    Blackard CE; Mellinger GT
    Postgrad Med; 1972 Mar; 51(3):140-5. PubMed ID: 4553219
    [No Abstract]   [Full Text] [Related]  

  • 5. Endocrine treatment of cancer of the prostate.
    Madsen PO; Pedersen JF; Knuth OE
    Wis Med J; 1970 Jul; 69(7):177-81. PubMed ID: 4916084
    [No Abstract]   [Full Text] [Related]  

  • 6. Paraplegia and paraparesis due to prostatic cancer. Use of intravenous diethylstilbestrol diphosphate.
    Hawtrey CE; Welch MJ; Schmidt JD; Culp DA; Flocks RH
    Urology; 1974 Oct; 4(4):431-4. PubMed ID: 4423432
    [No Abstract]   [Full Text] [Related]  

  • 7. An analysis of the effects of changes from the assigned treatment in a clinical trial of treatment for prostatic cancer.
    Hurst KS; Byar DP
    J Chronic Dis; 1973 May; 26(5):311-24. PubMed ID: 4578154
    [No Abstract]   [Full Text] [Related]  

  • 8. The Veterans' Administration Cooperative Urological Research Group studies of carcinoma of the prostate: a review.
    Blackard CE
    Cancer Chemother Rep; 1975; 59(1):225-7. PubMed ID: 1093670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: The Veterans Administration Cooperative Urological Research Group's studies of cancer of the prostate.
    Byar DP
    Cancer; 1973 Nov; 32(5):1126-30. PubMed ID: 4585929
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular side effects of diethylstilbestrol, cyproterone acetate, medroxyprogesterone acetate and estramustine phosphate used for the treatment of advanced prostatic cancer: results from European Organization for Research on Treatment of Cancer trials 30761 and 30762.
    de Voogt HJ; Smith PH; Pavone-Macaluso M; de Pauw M; Suciu S
    J Urol; 1986 Feb; 135(2):303-7. PubMed ID: 2935644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogens and cancer of the prostate.
    Kaplan L
    Surg Gynecol Obstet; 1969 Jan; 128(1):117. PubMed ID: 5774991
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic usefulness of serum acid phosphatase levels in carcinoma of the prostate.
    Ishibe T; Usui T; Nihira H
    J Urol; 1974 Aug; 112(2):237-40. PubMed ID: 4843340
    [No Abstract]   [Full Text] [Related]  

  • 13. Carcinoma of the prostate: treatment comparisons.
    J Urol; 1967 Oct; 98(4):516-22. PubMed ID: 4862213
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of orchiectomy and various doses of stilbestrol on plasma testosterone levels in patients with carcinoma of the prostate.
    Mackler MA; Liberti JP; Smith MJ; Prout GR
    Surg Forum; 1970; 21():540-1. PubMed ID: 5535268
    [No Abstract]   [Full Text] [Related]  

  • 15. Oestrogens for carcinoma of the prostate.
    Med J Aust; 1971 May; 1(19):991-2. PubMed ID: 5576836
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombosis and carcinoma of the prostate.
    Sutherland-Rawlings E
    Br Med J; 1970 Sep; 3(5723):643-4. PubMed ID: 5470096
    [No Abstract]   [Full Text] [Related]  

  • 17. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.
    Gleason DF; Mellinger GT
    J Urol; 1974 Jan; 111(1):58-64. PubMed ID: 4813554
    [No Abstract]   [Full Text] [Related]  

  • 18. Estrogen dosage and suppression of testosterone levels in patients with prostatic carcinoma.
    Kent JR; Bischoff AJ; Arduino LJ; Mellinger GT; Byar DP; Hill M; Kozbur X
    J Urol; 1973 May; 109(5):858-60. PubMed ID: 4699685
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral stilboestrol diphosphate ("Honvan") in the treatment of prostatic carcinoma: a clinical trial.
    Lambley DG; Ware JW
    Br J Urol; 1967 Apr; 39(2):147-52. PubMed ID: 5337817
    [No Abstract]   [Full Text] [Related]  

  • 20. Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Examined by the step-section technique.
    Byar DP; Mostofi FK
    Cancer; 1972 Jul; 30(1):5-13. PubMed ID: 5064808
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.